In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University Deal Valuations

Executive Summary

How do the financial terms of deals signed with university tech transfer offices differ when the licensor is a biotech, compared to a Big Pharma? We broke out university deals signed by these kinds of licensors to find out.

You may also be interested in...



Royalties in Tech Transfer Alliances

In Vivo reviews recent royalty rates in tech transfer-to-biotech licensing deals.

FDA Details Alternatives For COVID-19 Test Supplies

The US agency has released a document explaining what COVID-19 testing supplies may be substituted.

Curecumin Piques US Consumers’ Interest; UK Curiosity Grows For Omega-3, Survey Shows

Marketing consultant Buzzback surveyed 800 consumers in March, prior to novel coronavirus shutdowns in the two countries, to identify ingredients that offer opportunities for brands in health care, wellness and skin care.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1132583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel